Fulcrum Therapeutics Inc (FULC) ticks all the boxes for top investors with its surprise performance of 27.75% last month.

On November 20, 2023, Fulcrum Therapeutics Inc (NASDAQ: FULC) opened at $4.15, higher 12.05% from the last session. During the day, the shares moved up to $4.69 and dropped to $4.15 before settling in for the closing price of $4.15. Price fluctuations for FULC have ranged from $2.25 to $15.00 over the past 52 weeks.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 10.06%. Company’s average yearly earnings per share was noted 32.79% at the time writing. With a float of $58.13 million, this company’s outstanding shares have now reached $61.82 million.

The extent of productivity of a business whose workforce counts for 89 workers is very important to gauge. In terms of profitability, gross margin is +61.94, operating margin of -1768.12, and the pretax margin is -1732.43.

Fulcrum Therapeutics Inc (FULC) Insider and Institutional Ownership

A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Fulcrum Therapeutics Inc is 5.98%, while institutional ownership is 87.73%. The most recent insider transaction that took place on May 10, was worth 695. In this transaction Principal Accounting Officer of this company sold 210 shares at a rate of $3.31, taking the stock ownership to the 15,992 shares. Before that another transaction happened on Jan 20, when Company’s 10% Owner bought 1,923,076 for $13.00, making the entire transaction worth $24,999,988. This insider now owns 11,609,704 shares in total.

Fulcrum Therapeutics Inc (FULC) Latest Financial update

If we go through the results of last quarter, which was made public on 9/29/2023, the company posted -$0.39 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -$0.43) by $0.04. This company achieved a net margin of -1732.43 while generating a return on equity of -53.53. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.44 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 32.79% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.40% during the next five years compared to -17.57% drop over the previous five years of trading.

Fulcrum Therapeutics Inc (NASDAQ: FULC) Trading Performance Indicators

Check out the current performance indicators for Fulcrum Therapeutics Inc (FULC). In the past quarter, the stock posted a quick ratio of 18.65. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 109.72.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.69, a number that is poised to hit -0.43 in the next quarter and is forecasted to reach -1.80 in one year’s time.

Technical Analysis of Fulcrum Therapeutics Inc (FULC)

The latest stats from [Fulcrum Therapeutics Inc, FULC] show that its last 5-days average volume of 0.55 million was inferior to 1.28 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 71.16%. Additionally, its Average True Range was 0.36.

During the past 100 days, Fulcrum Therapeutics Inc’s (FULC) raw stochastic average was set at 46.32%, which indicates a significant decrease from 97.24% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 148.85% in the past 14 days, which was higher than the 101.47% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $3.99, while its 200-day Moving Average is $4.37. Now, the first resistance to watch is $4.84. This is followed by the second major resistance level at $5.04. The third major resistance level sits at $5.38. If the price goes on to break the first support level at $4.30, it is likely to go to the next support level at $3.96. The third support level lies at $3.76 if the price breaches the second support level.

Fulcrum Therapeutics Inc (NASDAQ: FULC) Key Stats

There are currently 61,823K shares outstanding in the company with a market cap of 287.46 million. Presently, the company’s annual sales total 6,340 K according to its annual income of -109,870 K. Last quarter, the company’s sales amounted to 760 K and its income totaled -24,020 K.


On What Basis Did Swvl Holdings Corp (SWVL) Stock Rise 47% Pre-Hours?

When last checked, Swvl Holdings Corp. (Nasdaq: SWVL), a...

What Drove Organovo (ONVO) Stock Up 15% In After-Hour Session On Tuesday?

Shares of Organovo Holdings Inc. (Nasdaq: ONVO) were up...

Is There Any Reason As To Why The Zai Lab (ZLAB) Stock Expanded By 13%?

The biopharmaceutical business Zai Lab Limited (NASDAQ: ZLAB), which...



Don't miss

Wearable Devices (WLDS) Stock Rose 12% On Tuesday, But On What Basis?

Wearable Devices Ltd (NASD: WLDS) is experiencing significant growth...

Did Anything Boost ObsEva (OBSV) Stock In Pre-Hours Trading?

Following an update, shares of ObsEva SA (NASD: OBSV)...

How Did The Kalera (KAL) Stock Rise 32% Pre-Hours?

At the time of the most recent check, shares...

Why Has Selina Hospitality (SLNA) Stock Increased In Extended Session On Friday?

The stock of Selina Hospitality PLC (NASD: SLNA), which...

Purple Innovation Inc (PRPL) is set for another landmark as it hit the volume of 1.33 million

Purple Innovation Inc (NASDAQ: PRPL) open the trading on November 30, 2023, with great promise as it jumped 0.68% to $0.62. During the day,...

uniQure N.V. (QURE) last month performance of 18.95% certainly makes it a sizzling prospect

Witnessing the stock’s movement on the chart, on November 30, 2023, uniQure N.V. (NASDAQ: QURE) had a quiet start as it plunged -0.29% to...

The key reasons why CRH Plc (CRH) is -0.25% away from 52-week high?

CRH Plc (NYSE: CRH) established initial surge of 0.37% at $62.75, as the Stock market unbolted on November 30, 2023. During the day, the...


Please enter your comment!
Please enter your name here